I disagree. I think there are many catalysts that would make you want to keep your money in until approval day. With the approval of Stendra, VVUS is no longer a $7 stock. Stendra has the possibility of taking a big chunk out of Viagra's market. Pfizer just made an announcement that they are looking for mid-size drug deals (http://www.reuters.com/article/2012/05/01/us-pfizer-idUSBRE8401GQ20120501?feedType=RSS&feedName=innovationNews&rpc=43). Plus. VVUS is holding a conference call on May 7th, which will keep all eyes on them. And technically, the FDA could announce approval any day... They don't HAVE to wait.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.